RSV is a 501(c)(3) public charity that applies private sector tactics and techniques to advancing global health equity. We identify innovations in science and technology that challenge and advance the norms of biopharma and health care delivery.

Our Approach

INVEST

.

INCUBATE

.

EDUCATE

.

INVEST . INCUBATE . EDUCATE .

Invest Image

Invest

We invest in early-stage companies with technologies that have the potential to make medicines more accessible for underserved patient groups.

Incubate Image

Incubate

We leverage the best of Roivant Sciences’ resources and talent to help social entrepreneurs at healthcare-focused startups with their strategy and approach to maximize their likelihood of success.

Educate Image

Educate

We embed Roivant’s drug development model into academic institutions, while providing fellowship and internship support to expand diversity at the highest levels of our industry and in clinical trials.

We are pioneering solutions to unmet needs and to ensuring global equitable access – and this is reflected in every aspect of our programmatic work. We partner with innovative companies, institutes and organizations to promote systemic, sustained improvements to the way health care is accessed and delivered. Through our unique approach we aim to generate substantial social returns and reinvest financial returns to drive change.

Our Focus Areas

This work includes:

  • Investing in and incubating early-stage companies that are working to bring new therapies to underserved patient groups.

  • Creating global access to gene therapies.

  • Increasing patient and physician diversity in clinical trials.

  • Building DEI opportunities for future leaders in biopharma and biotech.